[{"data": {"name": "PDB39 Evaluation of the Long-Term Clinical and Economic Impact of a 1% HbA1C Reduction in Patients With Type 2 Diabetes in Indonesia", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "L. Todorova", "@type": "Person"}, {"name": "P. Soewondo", "@type": "Person"}, {"name": "B. Hunt", "@type": "Person"}, {"name": "K. Suastika", "@type": "Person"}], "license": "elsevier-specific: oa user license", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.valueinhealthjournal.com/article/S1098301512033955/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Elsevier BV", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1016/j.jval.2012.08.1682", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCcm46PXWRY88-CTDYcRrM7Amab-CDUMApTvxqeNv-CRUsKiFnHA75N", "propertyID": "ISCC"}], "datePublished": "2012-11-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]